Teclistamab represents a groundbreaking advancement in the realm of cancer treatment. This novel antibody-drug conjugate targets BCMA, a protein overexpressed on the surface of multiple myeloma cells. By leveraging a https://montymsgl736177.wikiexpression.com/user